Cart
sales@molnova.com
IL-17 modulator 4
CAS No. 2446803-65-0
IL-17 modulator 4 ( —— )
Catalog No. M28072 CAS No. 2446803-65-0
IL-17 modulator 4 is a prodrug of IL-17 modulator 1 . IL-17 modulator 1 is an orally active, highly efficacious IL-17 modulator.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 390 | Get Quote |
|
| 5MG | 621 | Get Quote |
|
| 10MG | 1008 | Get Quote |
|
| 25MG | 2088 | Get Quote |
|
| 50MG | 3357 | Get Quote |
|
| 100MG | 4698 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameIL-17 modulator 4
-
NoteResearch use only, not for human use.
-
Brief DescriptionIL-17 modulator 4 is a prodrug of IL-17 modulator 1 . IL-17 modulator 1 is an orally active, highly efficacious IL-17 modulator.
-
DescriptionIL-17 modulator 4 is a prodrug of IL-17 modulator 1 . IL-17 modulator 1 is an orally active, highly efficacious IL-17 modulator.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorIRAK-4;IRAK-1;TAK1;CLK4
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2446803-65-0
-
Formula Weight474.6
-
Molecular FormulaC27H34N6O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESN/A
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.1. Scarneo SA, et al. A highly selective inhibitor of interleukin-1 receptor-associated kinases 1/4 (IRAK-1/4) delineates the distinct signaling roles of IRAK-1/4 and the TAK1 kinase. J Biol Chem. 2020 Feb 7;295(6):1565-1574.
molnova catalog
related products
-
N-BENZYLFORMAMIDE
N-BENZYLFORMAMIDE is a natural product from Lepidium meyenii Walp.
-
3-Geranyl-3-prenyl-2...
3'-Geranyl-3-prenyl-2',4',5,7-tetrahydroxyflavone is a natural product from Morus alba.
-
Glucagon-like peptid...
Glucagon-like peptide 1 (1-37), human (TFA) is a highly potent agonist of the GLP-1 receptor, it is a kind of pancreatic hormone synthesized by post-translational processing of proglucagon.
